Oral versus intramuscular cholecalciferol replacement in hemodialysis patients with vitamin D deficiency

Oral versus intramuscular cholecalciferol replacement in hemodialysis patients with vitamin D deficiency

Introduction: Low 25-hydroxyvitamin D (25(OH)D) level in hemodialysis (HD) patients is associated with high bone turnover, secondary hyperparathyroidism, and decreased bone mineral density (BMD). Objective: To investigate the efficacy of equivalent doses of pulse oral cholecalciferol versus intramus...

Full description

Bibliographic Details
Main Authors: Maha A. Behairy, Reem M. Elsharabasy, Abdel Bassit El Shaarawy, Walid Anwar, Zeinab Ahmed Mahmoud, Lina Essam Khedr
Format: Article
Language:English
Published: Society of Diabetic Nephropathy Prevention 2022-01-01
Series:Journal of Nephropharmacology
Subjects:
cholecalciferol
hemodialysis
25 oh vitamin d
hyperparathyroidism
Online Access:https://jnephropharmacology.com/PDF/npj-10383

Internet

https://jnephropharmacology.com/PDF/npj-10383

Similar Items